| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | NADH oxidase H202-forming activity | 5.61e-05 | 2 | 150 | 2 | GO:0106293 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 1.09e-04 | 144 | 150 | 7 | GO:0016798 | |
| GeneOntologyMolecularFunction | carbohydrate binding | SIGLEC12 MAN2C1 MAN2B1 GBE1 REG1A CEMIP LMAN1L MRC2 PPP1R3F GALNT4 | 1.21e-04 | 310 | 150 | 10 | GO:0030246 |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 1.28e-04 | 103 | 150 | 6 | GO:0004553 | |
| GeneOntologyMolecularFunction | mannose-ethanolamine phosphotransferase activity | 3.33e-04 | 4 | 150 | 2 | GO:0051377 | |
| GeneOntologyMolecularFunction | L-lactate dehydrogenase activity | 5.52e-04 | 5 | 150 | 2 | GO:0004459 | |
| GeneOntologyMolecularFunction | NADPH oxidase H202-forming activity | 5.52e-04 | 5 | 150 | 2 | GO:0106294 | |
| Domain | NPIP | 3.76e-06 | 14 | 150 | 4 | IPR009443 | |
| Domain | DUOX1 | 6.41e-05 | 2 | 150 | 2 | IPR029595 | |
| Domain | WASPfam_EVH1 | 6.41e-05 | 2 | 150 | 2 | IPR033927 | |
| Domain | - | 1.91e-04 | 3 | 150 | 2 | 1.10.1280.10 | |
| Domain | Unchr_di-copper_centre | 1.91e-04 | 3 | 150 | 2 | IPR008922 | |
| Domain | TYROSINASE_1 | 1.91e-04 | 3 | 150 | 2 | PS00497 | |
| Domain | TYROSINASE_2 | 1.91e-04 | 3 | 150 | 2 | PS00498 | |
| Domain | - | 1.91e-04 | 3 | 150 | 2 | 4.10.1130.10 | |
| Domain | Tyrosinase | 1.91e-04 | 3 | 150 | 2 | PF00264 | |
| Domain | Tyrosinase_Cu-bd | 1.91e-04 | 3 | 150 | 2 | IPR002227 | |
| Domain | PTPc | 1.93e-04 | 36 | 150 | 4 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 2.64e-04 | 39 | 150 | 4 | PS50055 | |
| Domain | PTPase_domain | 3.21e-04 | 41 | 150 | 4 | IPR000242 | |
| Domain | Y_phosphatase | 3.21e-04 | 41 | 150 | 4 | PF00102 | |
| Domain | Coact_PPARg | 3.80e-04 | 4 | 150 | 2 | IPR026784 | |
| Domain | Fd_Rdtase_FAD-bd | 4.48e-04 | 19 | 150 | 3 | IPR017927 | |
| Domain | FAD_FR | 4.48e-04 | 19 | 150 | 3 | PS51384 | |
| Domain | Riboflavin_synthase-like_b-brl | 4.48e-04 | 19 | 150 | 3 | IPR017938 | |
| Domain | Glyco_hydro_38_C | 6.31e-04 | 5 | 150 | 2 | IPR011682 | |
| Domain | Alpha-mann_mid | 6.31e-04 | 5 | 150 | 2 | PF09261 | |
| Domain | Glyco_hydro_57/38_cen | 6.31e-04 | 5 | 150 | 2 | IPR028995 | |
| Domain | L_LDH | 6.31e-04 | 5 | 150 | 2 | PS00064 | |
| Domain | Glyco_hydro_38 | 6.31e-04 | 5 | 150 | 2 | PF01074 | |
| Domain | - | 6.31e-04 | 5 | 150 | 2 | 1.20.1270.50 | |
| Domain | - | 6.31e-04 | 5 | 150 | 2 | 3.20.110.10 | |
| Domain | Alpha-mann_mid | 6.31e-04 | 5 | 150 | 2 | SM00872 | |
| Domain | L-lactate_DH | 6.31e-04 | 5 | 150 | 2 | IPR011304 | |
| Domain | L-lactate_DH_AS | 6.31e-04 | 5 | 150 | 2 | IPR018177 | |
| Domain | Glyco_hydro_38_N | 6.31e-04 | 5 | 150 | 2 | IPR000602 | |
| Domain | Glyco_hydro_38/57_N | 6.31e-04 | 5 | 150 | 2 | IPR027291 | |
| Domain | DMAP_binding | 6.31e-04 | 5 | 150 | 2 | PF06464 | |
| Domain | Glyco_hydro_38_cen | 6.31e-04 | 5 | 150 | 2 | IPR015341 | |
| Domain | Glyco_hydro_38C | 6.31e-04 | 5 | 150 | 2 | PF07748 | |
| Domain | DMAP1-bd | 9.41e-04 | 6 | 150 | 2 | IPR010506 | |
| Domain | Peptidase_S8_Asp-AS | 9.41e-04 | 6 | 150 | 2 | IPR023827 | |
| Domain | WxxW_domain | 9.41e-04 | 6 | 150 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 9.41e-04 | 6 | 150 | 2 | PF13330 | |
| Domain | DMAP_binding | 9.41e-04 | 6 | 150 | 2 | SM01137 | |
| Domain | WD40 | 1.19e-03 | 259 | 150 | 8 | PF00400 | |
| Domain | PTPc_motif | 1.29e-03 | 59 | 150 | 4 | SM00404 | |
| Domain | Tyr_Pase_cat | 1.29e-03 | 59 | 150 | 4 | IPR003595 | |
| Domain | WASP_C | 1.31e-03 | 7 | 150 | 2 | IPR011026 | |
| Domain | P_proprotein | 1.31e-03 | 7 | 150 | 2 | PF01483 | |
| Domain | S8_pro-domain | 1.31e-03 | 7 | 150 | 2 | IPR032815 | |
| Domain | PrprotnconvertsP | 1.31e-03 | 7 | 150 | 2 | IPR002884 | |
| Domain | Glyco_hydro/deAcase_b/a-brl | 1.31e-03 | 7 | 150 | 2 | IPR011330 | |
| Domain | NAD_binding_6 | 1.31e-03 | 7 | 150 | 2 | PF08030 | |
| Domain | FAD_binding_8 | 1.31e-03 | 7 | 150 | 2 | PF08022 | |
| Domain | - | 1.31e-03 | 7 | 150 | 2 | 3.30.70.850 | |
| Domain | S8_pro-domain | 1.31e-03 | 7 | 150 | 2 | PF16470 | |
| Domain | FAD-bd_8 | 1.31e-03 | 7 | 150 | 2 | IPR013112 | |
| Domain | Fe_red_NAD-bd_6 | 1.31e-03 | 7 | 150 | 2 | IPR013121 | |
| Domain | WD40 | 1.48e-03 | 268 | 150 | 8 | SM00320 | |
| Domain | WD40_repeat | 1.62e-03 | 272 | 150 | 8 | IPR001680 | |
| Domain | Lactate/malate_DH_N | 1.74e-03 | 8 | 150 | 2 | IPR001236 | |
| Domain | L-lactate/malate_DH | 1.74e-03 | 8 | 150 | 2 | IPR001557 | |
| Domain | Ldh_1_N | 1.74e-03 | 8 | 150 | 2 | PF00056 | |
| Domain | WD_REPEATS_1 | 1.86e-03 | 278 | 150 | 8 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.90e-03 | 279 | 150 | 8 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.90e-03 | 279 | 150 | 8 | PS50294 | |
| Domain | fn3 | 1.99e-03 | 162 | 150 | 6 | PF00041 | |
| Domain | Peptidase_S8_His-AS | 2.22e-03 | 9 | 150 | 2 | IPR022398 | |
| Domain | BTK | 2.22e-03 | 9 | 150 | 2 | SM00107 | |
| Domain | - | 2.22e-03 | 9 | 150 | 2 | 3.90.110.10 | |
| Domain | Lactate/malate_DH_C | 2.22e-03 | 9 | 150 | 2 | IPR022383 | |
| Domain | Ldh_1_C | 2.22e-03 | 9 | 150 | 2 | PF02866 | |
| Domain | Peptidase_S8_Ser-AS | 2.22e-03 | 9 | 150 | 2 | IPR023828 | |
| Domain | Lactate_DH/Glyco_Ohase_4_C | 2.22e-03 | 9 | 150 | 2 | IPR015955 | |
| Domain | Znf_Btk_motif | 2.22e-03 | 9 | 150 | 2 | IPR001562 | |
| Domain | BTK | 2.22e-03 | 9 | 150 | 2 | PF00779 | |
| Domain | ZF_BTK | 2.22e-03 | 9 | 150 | 2 | PS51113 | |
| Domain | PH_dom-like | 2.36e-03 | 426 | 150 | 10 | IPR011993 | |
| Domain | An_peroxidase | 2.76e-03 | 10 | 150 | 2 | PF03098 | |
| Domain | Haem_peroxidase_animal | 2.76e-03 | 10 | 150 | 2 | IPR019791 | |
| Domain | Phosphodiest/P_Trfase | 2.76e-03 | 10 | 150 | 2 | IPR002591 | |
| Domain | Peptidase_S8_subtilisin-rel | 2.76e-03 | 10 | 150 | 2 | IPR015500 | |
| Domain | Haem_peroxidase | 2.76e-03 | 10 | 150 | 2 | IPR010255 | |
| Domain | Phosphodiest | 2.76e-03 | 10 | 150 | 2 | PF01663 | |
| Domain | PEROXIDASE_3 | 2.76e-03 | 10 | 150 | 2 | PS50292 | |
| Domain | SUBTILASE_ASP | 2.76e-03 | 10 | 150 | 2 | PS00136 | |
| Domain | SUBTILASE_HIS | 2.76e-03 | 10 | 150 | 2 | PS00137 | |
| Domain | SUBTILASE_SER | 2.76e-03 | 10 | 150 | 2 | PS00138 | |
| Domain | - | 2.76e-03 | 10 | 150 | 2 | 1.10.640.10 | |
| Domain | WD40_repeat_dom | 2.79e-03 | 297 | 150 | 8 | IPR017986 | |
| Domain | Tyr_Pase_AS | 2.83e-03 | 73 | 150 | 4 | IPR016130 | |
| Domain | - | 3.36e-03 | 11 | 150 | 2 | 3.40.50.200 | |
| Domain | WH1 | 3.36e-03 | 11 | 150 | 2 | SM00461 | |
| Domain | Peptidase_S8/S53_dom | 3.36e-03 | 11 | 150 | 2 | IPR000209 | |
| Domain | WH1/EVH1_dom | 3.36e-03 | 11 | 150 | 2 | IPR000697 | |
| Domain | WH1 | 3.36e-03 | 11 | 150 | 2 | PF00568 | |
| Domain | Peptidase_S8 | 3.36e-03 | 11 | 150 | 2 | PF00082 | |
| Domain | FN3 | 3.84e-03 | 185 | 150 | 6 | SM00060 | |
| Domain | - | 4.01e-03 | 12 | 150 | 2 | 3.90.810.10 | |
| Domain | Ferric_reduct | 4.01e-03 | 12 | 150 | 2 | PF01794 | |
| Domain | Fe3_Rdtase_TM_dom | 4.01e-03 | 12 | 150 | 2 | IPR013130 | |
| Domain | - | 4.39e-03 | 391 | 150 | 9 | 2.30.29.30 | |
| Domain | Ig-like_fold | SIGLEC12 IGFN1 HLA-DMA OBSCN GBE1 PTPRT LY6G6F PTPRJ TRIM9 VSTM2L IGSF9 FGFR3 ADGRF3 | 4.59e-03 | 706 | 150 | 13 | IPR013783 |
| Domain | WH1 | 4.72e-03 | 13 | 150 | 2 | PS50229 | |
| Domain | TYR_PHOSPHATASE_1 | 5.10e-03 | 86 | 150 | 4 | PS00383 | |
| Domain | TYR_PHOSPHATASE_dom | 5.31e-03 | 87 | 150 | 4 | IPR000387 | |
| Pubmed | 9.07e-17 | 12 | 162 | 8 | 10433963 | ||
| Pubmed | 2.35e-16 | 13 | 162 | 8 | 17668377 | ||
| Pubmed | The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. | 3.33e-16 | 8 | 162 | 7 | 17588759 | |
| Pubmed | 4.95e-15 | 10 | 162 | 7 | 17984056 | ||
| Pubmed | 7.00e-14 | 13 | 162 | 7 | 7739628 | ||
| Pubmed | Active genes in junk DNA? Characterization of DUX genes embedded within 3.3 kb repeated elements. | 7.81e-13 | 17 | 162 | 7 | 11245978 | |
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | WASL WAS COPA WRNIP1 GBE1 SH2D2A LDHA PRDX6 JAK3 PTPRA FAM120A SQSTM1 | 4.98e-08 | 327 | 162 | 12 | 15592455 |
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 17911620 | ||
| Pubmed | The homeobox transcription factor DUXBL controls exit from totipotency. | 3.95e-07 | 4 | 162 | 3 | 38509386 | |
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 29274231 | ||
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 20063414 | ||
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 20221248 | ||
| Pubmed | The transcription factor Duxbl mediates elimination of pre-T cells that fail β-selection. | 3.42e-06 | 7 | 162 | 3 | 30765463 | |
| Pubmed | Clustering of six human 11p15 gene homologs within a 500-kb interval of proximal mouse chromosome 7. | 3.42e-06 | 7 | 162 | 3 | 7698755 | |
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 1932742 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | PIGN FAT4 EOGT ATP6AP1 MAN2B1 COPA TM9SF1 PTPN12 MEGF8 PTPRJ MRC2 SQSTM1 FURIN CPSF1 ADAM17 ATP2A3 PIGO DNASE2 GALNT4 | 3.60e-06 | 1201 | 162 | 19 | 35696571 |
| Pubmed | 5.46e-06 | 8 | 162 | 3 | 7782070 | ||
| Pubmed | 1.59e-05 | 11 | 162 | 3 | 8581564 | ||
| Pubmed | Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism. | 2.16e-05 | 2 | 162 | 2 | 28633507 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 1292007 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 20071778 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 20599953 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 33054763 | ||
| Pubmed | CAPRI regulates Ca(2+)-dependent inactivation of the Ras-MAPK pathway. | 2.16e-05 | 2 | 162 | 2 | 11448776 | |
| Pubmed | Reactive oxygen species regulate the levels of dual oxidase (Duox1-2) in human neuroblastoma cells. | 2.16e-05 | 2 | 162 | 2 | 22523549 | |
| Pubmed | Expression of dual oxidases and secreted cytokines in chronic rhinosinusitis. | 2.16e-05 | 2 | 162 | 2 | 23281318 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 30590713 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 10092676 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 31706280 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 19727732 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 28886181 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 11584271 | ||
| Pubmed | Dual oxidase-2 has an intrinsic Ca2+-dependent H2O2-generating activity. | 2.16e-05 | 2 | 162 | 2 | 15972824 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 24025154 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 38085658 | ||
| Pubmed | Identification of mutations in the pigment cell-specific gene located at the brown locus in mouse. | 2.16e-05 | 2 | 162 | 2 | 1409444 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 23362256 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 19144650 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 24145033 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 12141946 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 11762710 | ||
| Pubmed | Characterization of ThOX proteins as components of the thyroid H(2)O(2)-generating system. | 2.16e-05 | 2 | 162 | 2 | 11822874 | |
| Pubmed | Tyrosinase-related protein-2 and -1 are trafficked on distinct routes in B16 melanoma cells. | 2.16e-05 | 2 | 162 | 2 | 15707965 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 34743698 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 18177232 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 31559637 | ||
| Pubmed | Structural mechanism of WASP activation by the enterohaemorrhagic E. coli effector EspF(U). | 2.16e-05 | 2 | 162 | 2 | 18650809 | |
| Pubmed | Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. | 2.16e-05 | 2 | 162 | 2 | 12824283 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 1590786 | ||
| Pubmed | Congenital Hypothyroidism due to Oligogenic Mutations in Two Sudanese Families. | 2.16e-05 | 2 | 162 | 2 | 30375286 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 12972643 | ||
| Pubmed | Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. | 2.16e-05 | 2 | 162 | 2 | 10806195 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 11514595 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 8530077 | ||
| Pubmed | A cDNA encoding tyrosinase-related protein maps to the brown locus in mouse. | 2.16e-05 | 2 | 162 | 2 | 3132713 | |
| Pubmed | Roles of DUOX-mediated hydrogen peroxide in metabolism, host defense, and signaling. | 2.16e-05 | 2 | 162 | 2 | 24161126 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 23527602 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 31916311 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 11443211 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 10601291 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 38172445 | ||
| Pubmed | Human lactate dehydrogenase A (LDHA) rescues mouse Ldhc-null sperm function. | 2.16e-05 | 2 | 162 | 2 | 23467744 | |
| Pubmed | Complex signatures of selection for the melanogenic loci TYR, TYRP1 and DCT in humans. | 2.16e-05 | 2 | 162 | 2 | 18312627 | |
| Pubmed | Abundance of repetitive sequence elements in the mouse testis-specific lactate dehydrogenase-C gene. | 2.16e-05 | 2 | 162 | 2 | 14581519 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 18713856 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 25586178 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 8422932 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 16111680 | ||
| Pubmed | X-ray scattering study of activated Arp2/3 complex with bound actin-WCA. | 2.16e-05 | 2 | 162 | 2 | 18462674 | |
| Pubmed | Dual oxidase 1-dependent MUC5AC mucin expression in cultured human airway epithelial cells. | 2.16e-05 | 2 | 162 | 2 | 15640347 | |
| Pubmed | Nox/Duox family of nicotinamide adenine dinucleotide (phosphate) oxidases. | 2.16e-05 | 2 | 162 | 2 | 11753072 | |
| Pubmed | Silencing of DUOX NADPH oxidases by promoter hypermethylation in lung cancer. | 2.16e-05 | 2 | 162 | 2 | 18281478 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 15062544 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 20123016 | ||
| Pubmed | Wiskott Aldrich syndrome protein (WASP) and N-WASP are critical for T cell development. | 2.16e-05 | 2 | 162 | 2 | 17878299 | |
| Pubmed | Regulated hydrogen peroxide production by Duox in human airway epithelial cells. | 2.16e-05 | 2 | 162 | 2 | 15677770 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 16041389 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 24128054 | ||
| Pubmed | 2.74e-05 | 13 | 162 | 3 | 19859091 | ||
| Pubmed | ATP6AP1 ILK MAN2B1 COPA LDHA NUP205 MEGF8 PTPRJ MRC2 AFG3L2 ADAM17 DNASE2 | 3.30e-05 | 613 | 162 | 12 | 22268729 | |
| Pubmed | 3.30e-05 | 129 | 162 | 6 | 28973437 | ||
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 3.39e-05 | 262 | 162 | 8 | 36880596 | |
| Pubmed | 4.33e-05 | 15 | 162 | 3 | 35727972 | ||
| Pubmed | 4.33e-05 | 15 | 162 | 3 | 21205794 | ||
| Pubmed | 4.33e-05 | 15 | 162 | 3 | 30071041 | ||
| Pubmed | 4.33e-05 | 15 | 162 | 3 | 8892864 | ||
| Pubmed | Molecular analysis of 36 mutations at the mouse pink-eyed dilution (p) locus. | 5.31e-05 | 16 | 162 | 3 | 8601494 | |
| Pubmed | Dissecting and manipulating the pathway for glycosylphos-phatidylinositol-anchor biosynthesis. | 6.43e-05 | 17 | 162 | 3 | 11102867 | |
| Pubmed | Protein tyrosine phosphatases expression during development of mouse superior colliculus. | 6.43e-05 | 17 | 162 | 3 | 19727691 | |
| Pubmed | 6.45e-05 | 3 | 162 | 2 | 8825647 | ||
| Pubmed | Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism. | 6.45e-05 | 3 | 162 | 2 | 27708054 | |
| Pubmed | Nitric oxide is an activity-dependent regulator of target neuron intrinsic excitability. | 6.45e-05 | 3 | 162 | 2 | 21791288 | |
| Pubmed | CD28 inhibits T cell adhesion by recruiting CAPRI to the plasma membrane. | 6.45e-05 | 3 | 162 | 2 | 25637021 | |
| Pubmed | Tyrosinase gene family and Vogt-Koyanagi-Harada disease in Japanese patients. | 6.45e-05 | 3 | 162 | 2 | 17200659 | |
| Pubmed | 6.45e-05 | 3 | 162 | 2 | 32922204 | ||
| Pubmed | 6.45e-05 | 3 | 162 | 2 | 26881964 | ||
| Pubmed | 6.45e-05 | 3 | 162 | 2 | 17766092 | ||
| Pubmed | 6.45e-05 | 3 | 162 | 2 | 11340081 | ||
| Pubmed | 6.45e-05 | 3 | 162 | 2 | 17853776 | ||
| Pubmed | Excreted-secreted antigens of Toxoplasma gondii inhibit Foxp3 via IL-2Rγ/JAK3/Stats pathway. | 6.45e-05 | 3 | 162 | 2 | 30129110 | |
| Cytoband | 4q35.2 | 4.90e-10 | 27 | 162 | 6 | 4q35.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q35 | 9.94e-09 | 117 | 162 | 8 | chr4q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 1.92e-04 | 564 | 162 | 9 | chr11p15 | |
| Cytoband | 16p12.2 | 3.07e-04 | 37 | 162 | 3 | 16p12.2 | |
| GeneFamily | PRD class homeoboxes and pseudogenes | 1.46e-06 | 92 | 110 | 7 | 521 | |
| GeneFamily | WD repeat domain containing | 2.00e-04 | 262 | 110 | 8 | 362 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 2.69e-04 | 21 | 110 | 3 | 813 | |
| GeneFamily | Glycosyl transferases group 1 domain containing|Phosphatidylinositol glycan anchor biosynthesis | 2.69e-04 | 21 | 110 | 3 | 680 | |
| GeneFamily | Mannosidases alpha class 2 | 3.62e-04 | 5 | 110 | 2 | 1194 | |
| GeneFamily | Fibronectin type III domain containing | 4.39e-04 | 160 | 110 | 6 | 555 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 7.55e-04 | 7 | 110 | 2 | 1201 | |
| GeneFamily | Proprotein convertase subtilisin/kexin family | 1.28e-03 | 9 | 110 | 2 | 973 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 1.60e-03 | 10 | 110 | 2 | 830 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.04e-03 | 161 | 110 | 5 | 593 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 4.16e-03 | 16 | 110 | 2 | 14 | |
| ToppCell | COPD|World / Disease state, Lineage and Cell class | 4.74e-06 | 189 | 156 | 7 | 53577632683686dc493a5a3fdc01887ec5c320f2 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-MAIT|lymph-node_spleen / Manually curated celltypes from each tissue | 4.74e-06 | 189 | 156 | 7 | afe3a4fe7c10eeeb7064129778d940269c9acbef | |
| ToppCell | IPF-Lymphoid-NK|Lymphoid / Disease state, Lineage and Cell class | 5.08e-06 | 191 | 156 | 7 | f2ddc0962007d7a4e78fbd916ebb62fc557d480a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.22e-06 | 197 | 156 | 7 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.65e-06 | 199 | 156 | 7 | 9df2c79904dacf029ec9df1f1cde72d871189a82 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.65e-06 | 199 | 156 | 7 | 85bb28369e0568b7b3bda095722102fc793f60ef | |
| ToppCell | COVID-19_Mild-PLT_1|COVID-19_Mild / Disease Group and Platelet Clusters | 6.65e-06 | 199 | 156 | 7 | 7f32958a73bc6020ea8a0e595ec749bbfe74c1b3 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Macroglial-Glia_progenitor_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 6.87e-06 | 200 | 156 | 7 | fc9e2094f4d22412e3dd79e79649a6d46d62caec | |
| ToppCell | facs-Heart-RV-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.20e-06 | 135 | 156 | 6 | 99e7ac9b1139fe4ff036f6f048a8f1cc514c1fb9 | |
| ToppCell | facs-Heart-RV-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.20e-06 | 135 | 156 | 6 | 1fe684ed5913ae757ad6befbbe12d1bee481dd12 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.30e-06 | 138 | 156 | 6 | 6b83c434895d82eaf3c222eef27acec76f9c0a77 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-4|TCGA-Kidney / Sample_Type by Project: Shred V9 | 2.15e-05 | 160 | 156 | 6 | 45cb62a5186f3dd2a2fb86a8ebc952efb78e5e77 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_mature_unknown_2|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.39e-05 | 163 | 156 | 6 | e393e5ff885a42b2b44e430d3d5a58f5e50eb732 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.39e-05 | 163 | 156 | 6 | e526104a3a574ee860078ce7c049e7fec9443f37 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.93e-05 | 169 | 156 | 6 | 20fbf78382fb0ba9a63ab1aa0abc615476994ac5 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.93e-05 | 169 | 156 | 6 | c6e5b179461996ced6c7621dc01cec00d401f4e8 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.13e-05 | 171 | 156 | 6 | 6a2f88c2a62cb2f69797804e24eb1137a3e148de | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.13e-05 | 171 | 156 | 6 | 9be3554626408bb897d1f1c43b3ab4a92651f2e2 | |
| ToppCell | COVID-19-Heart-Fib_+_CM|Heart / Disease (COVID-19 only), tissue and cell type | 3.28e-05 | 104 | 156 | 5 | 0b60a56a46f1fe3f8224ec6399d009a34a117a21 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-05 | 173 | 156 | 6 | 3059325901b1e5e12a1a91183f14267288b2f600 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.34e-05 | 173 | 156 | 6 | efb8072475000888efe088d00e870c56ffad4172 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-05 | 173 | 156 | 6 | 9ba55e21d1037ec3150d77895e52f0b051df65da | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-05 | 173 | 156 | 6 | 36c8338463ee4cc432f568728d55989360f9a68d | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.45e-05 | 174 | 156 | 6 | 33d6b81f31bfcb9c4b30206d88e20b9a94fba4a2 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.45e-05 | 174 | 156 | 6 | 58300d64d3b6fd9ba1b6c87ea83b2777eb6be2f4 | |
| ToppCell | LPS-antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.92e-05 | 178 | 156 | 6 | 289d1425c4e57fabcca994b27f9af1c0ce5d5bec | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.92e-05 | 178 | 156 | 6 | 0b398656f26c4061b11ccf98908d0e2e1367585a | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.43e-05 | 182 | 156 | 6 | 7b86703559438e2d5ef3dad963ee0d772513f313 | |
| ToppCell | facs-Trachea-nan-24m-Lymphocytic|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.57e-05 | 183 | 156 | 6 | 568c7e3bde7c6ad2c28ec02c2b073f482c337698 | |
| ToppCell | facs-Trachea-nan-24m-Lymphocytic-T_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.57e-05 | 183 | 156 | 6 | 2b3ecfc51cdc5333345692747f4fed4c746a769d | |
| ToppCell | facs-Trachea-nan-24m-Lymphocytic-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.57e-05 | 183 | 156 | 6 | 79d7aac3b2483ca32430af5ac9f0e578ae064894 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.57e-05 | 183 | 156 | 6 | 3cbe0175d05fd39bc430de1ef471ff2c5b56460e | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-05 | 184 | 156 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-CD8_TRM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.71e-05 | 184 | 156 | 6 | 17ffa0e890960c00a3b5fa33d48caba66c61dbb0 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-05 | 184 | 156 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-05 | 184 | 156 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Bladder-BLADDER-1m-Hematologic-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.86e-05 | 185 | 156 | 6 | 969248b63d4ce335f223528de756bcddffadbd77 | |
| ToppCell | facs-Trachea-24m-Hematologic-lymphocytic-T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.16e-05 | 187 | 156 | 6 | e4a219483118288d414d9017b81927255a5ab8bb | |
| ToppCell | facs-Trachea-24m-Hematologic-lymphocytic-T_cell-T_cell_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.16e-05 | 187 | 156 | 6 | 81286565fcd51252c444e490b5f6d401c83b4666 | |
| ToppCell | COPD-Lymphoid-NK|COPD / Disease state, Lineage and Cell class | 5.31e-05 | 188 | 156 | 6 | c9a227c8e71b69929d43e9afb8306a95c8163778 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.31e-05 | 188 | 156 | 6 | 977ebc0f88cb3ea3c422c85d84b3546229af5d3f | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-MMP9+_Inflammatory_macrophage|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.31e-05 | 188 | 156 | 6 | f955f2eb92f399958d4d713e31af77d93fb4a6ec | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 5.31e-05 | 188 | 156 | 6 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | COPD-Lymphoid-NK|World / Disease state, Lineage and Cell class | 5.47e-05 | 189 | 156 | 6 | c0ac160fa7e68b92414fb1600abcac8ad1a42232 | |
| ToppCell | IPF-Lymphoid-NK|IPF / Disease state, Lineage and Cell class | 5.47e-05 | 189 | 156 | 6 | d92e880162450f8d01e4b8784eb625275cb8e03e | |
| ToppCell | Control-Lymphoid-NK|World / Disease state, Lineage and Cell class | 5.47e-05 | 189 | 156 | 6 | 89ef0d0e66dc96cacaae6be7aacdaa884e8e66a8 | |
| ToppCell | Control-Lymphoid-NK|Lymphoid / Disease state, Lineage and Cell class | 5.63e-05 | 190 | 156 | 6 | 1584c68b58c7f406d9b0e8451beea3e6f8980c56 | |
| ToppCell | Control-Lymphoid-NK|Control / Disease state, Lineage and Cell class | 5.63e-05 | 190 | 156 | 6 | f7bd8521a40ac30a64dc439f17e2f6c7d021ef65 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.80e-05 | 191 | 156 | 6 | 8a5a2188b13ef4bbfd626a42565566708a751c1b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.80e-05 | 191 | 156 | 6 | 96a7179a845d3daa046ed71fa45c51255f130a7f | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.80e-05 | 191 | 156 | 6 | e314dd8f1a841cab847ae3703bedfe1bc623ac61 | |
| ToppCell | IPF-Lymphoid-NK|World / Disease state, Lineage and Cell class | 5.80e-05 | 191 | 156 | 6 | f206159b9d5e84cf14a65bfdc008895cec5a8081 | |
| ToppCell | Megakaryocytic-erythropoietic-Megakaryo-cells-Platelet|Megakaryo-cells / Lineage, cell class and subclass | 5.97e-05 | 192 | 156 | 6 | a061db719d87209b56d074afbdeab37aa0079419 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.97e-05 | 192 | 156 | 6 | a06d5d3c2537f8d2b1dc6b6f3e88a80b5c2a1850 | |
| ToppCell | CD8+_Memory_T_cell-CV-0|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 6.14e-05 | 193 | 156 | 6 | 995781d87a919c0380750878bafe584342bb83ad | |
| ToppCell | COPD-Lymphoid-NK|Lymphoid / Disease state, Lineage and Cell class | 6.14e-05 | 193 | 156 | 6 | 0020249fa71afb500af73700543bb6f349be6b10 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.32e-05 | 194 | 156 | 6 | 4b208bb429a1e3d58a9b757b05ef4df85a1e7f1e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.50e-05 | 195 | 156 | 6 | 0ec1b572bbb92b6da3440139366a4c1743b1ad92 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.50e-05 | 195 | 156 | 6 | 2394e75cf493d8bc2e638ecb425386265176dd41 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.69e-05 | 196 | 156 | 6 | eb7d6bbfb766cdeaf5fe0f0bb66a5f491fd5ef26 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.69e-05 | 196 | 156 | 6 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK-NK_CD16|bone_marrow / Manually curated celltypes from each tissue | 6.69e-05 | 196 | 156 | 6 | a3b077e82b1550eb328c84b567b60179001f9a77 | |
| ToppCell | Fibroblast|World / shred by cell class for bronchial biopsy | 6.88e-05 | 197 | 156 | 6 | 8bf9846228b6b6721b10375fe54a2fb389ff64a6 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-CX3CR1+_Mac|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.88e-05 | 197 | 156 | 6 | 701334bc164e3b41132232f27574a87e9c3a5be5 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.88e-05 | 197 | 156 | 6 | 5a63c2b824c7d0dbbc706e408459c9b9fe65daaa | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.88e-05 | 197 | 156 | 6 | 9ee927d005eb17843e2516c8006eb192c6ad2af8 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.07e-05 | 198 | 156 | 6 | dbae6a58cb3ce8612755fbdba6194b70b35f258a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.07e-05 | 198 | 156 | 6 | 3371276410dba693c238b383d990b89371b14d8d | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.07e-05 | 198 | 156 | 6 | 7063d74d79f53d5c59c853a2575f9d3ef12f19ea | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-CD8_GZMK+|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.07e-05 | 198 | 156 | 6 | 54bb3d7e6bff9b5919b531417063e68d225c6d1c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.07e-05 | 198 | 156 | 6 | 1a189b2b213099505c5d871fb8aedd55a97d44e0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_ILC|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.07e-05 | 198 | 156 | 6 | 716c27d2a37b5f865b9d191e1851917340b400af | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.07e-05 | 198 | 156 | 6 | 399760b6b6fef8639ded53b14f251b9fce600e81 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.07e-05 | 198 | 156 | 6 | d021d0edb6aba2f15c51a3ec4e08c7233d0c1962 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.07e-05 | 198 | 156 | 6 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.07e-05 | 198 | 156 | 6 | b12914c3c5b8dd628cb456cb40283c5016641872 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.07e-05 | 198 | 156 | 6 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.27e-05 | 199 | 156 | 6 | 28c1722deef3b8347371c7359be7c64b95780de3 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.27e-05 | 199 | 156 | 6 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | (04)_Interm._basal>secr.|World / shred by cell type by condition | 7.27e-05 | 199 | 156 | 6 | ed399244433f781fc291a9bff16825b8a3ca294f | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.27e-05 | 199 | 156 | 6 | b68648b4559e452656dc9e6a0974233e842f5e0d | |
| ToppCell | Transverse-T_cell-gd_T|T_cell / Region, Cell class and subclass | 7.27e-05 | 199 | 156 | 6 | 8baea162803cea7d72dff5866a0eebfcf2e5dcd6 | |
| ToppCell | distal-2-Epithelial-Ciliated|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.27e-05 | 199 | 156 | 6 | 97b66b82c76c7bc1fcd7da7b94dd2aa2d4d70a60 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.48e-05 | 200 | 156 | 6 | c22cbfecee00183dd4be678f116ab9fd9ad0a4dd | |
| ToppCell | distal-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.48e-05 | 200 | 156 | 6 | 12b705dabec1b3752a488a891eda1a5123fcdc41 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD56bright|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.48e-05 | 200 | 156 | 6 | 1db27223e307efca97502fca40ec5e4f8eea512b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.48e-05 | 200 | 156 | 6 | 2cca77b2c9d829daa674a844e068f2b083e90d6e | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.48e-05 | 200 | 156 | 6 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | medial-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.48e-05 | 200 | 156 | 6 | cc6062dac07916c29091fc6bee2b864d29e6525b | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD3|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.48e-05 | 200 | 156 | 6 | 6b34f2b85d4f83c1270ee151f602cba6f42042ba | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.48e-05 | 200 | 156 | 6 | 5c0716bf375c8158f7dc2c82bf5eaf37af594dd0 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD3-NKT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.48e-05 | 200 | 156 | 6 | b2c5618aa1ac19423996336795dadb39ea57cda7 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 7.48e-05 | 200 | 156 | 6 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| ToppCell | LPS-antiTNF-Myeloid-Myeloid_granulocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 143 | 156 | 5 | 4a0f26eef935fe68a1da5d319503059a8a8682dd | |
| ToppCell | LPS-antiTNF-Myeloid-Myeloid_granulocytic-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 143 | 156 | 5 | 65328a0a2f3972fac596e07933e74b2ef7cceb84 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.74e-04 | 148 | 156 | 5 | 80470353e12599440f711b6e107730763376d04d | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.74e-04 | 148 | 156 | 5 | 065177aaa63c0441d312260b43ecdac78c84ad03 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.80e-04 | 149 | 156 | 5 | 3378d0fe79de6d7879fd48717ded5027593c785f | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4-POLYDENDROCYTE_(Neurogenesis.Sox4.Efhd2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.97e-04 | 82 | 156 | 4 | 93b75f8822ffe8870195cd1fe0a7286478f61e79 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Trm_Tgd|lymph-node_spleen / Manually curated celltypes from each tissue | 2.10e-04 | 154 | 156 | 5 | 51ffb3fa0250bd31be764ed048728aa064056e16 | |
| Drug | N-acetylhexosamine | MAN2C1 MAN2B1 ACP5 NEU3 REG1A RENBP PRDX6 LMAN1L FCSK OVGP1 FURIN AOC3 GFPT2 PCSK4 MUC5AC | 7.30e-07 | 472 | 153 | 15 | CID000000899 |
| Drug | periodic acid | ATP6AP1 MAN2C1 MAN2B1 WAS ACP5 GBE1 NEU3 PRDX6 LMAN1L MUC5AC | 1.32e-06 | 205 | 153 | 10 | CID000065185 |
| Drug | argiopine | 3.35e-06 | 16 | 153 | 4 | CID000122294 | |
| Drug | Riboflavine [83-88-5]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 8.04e-06 | 198 | 153 | 9 | 2760_UP | |
| Drug | oxypurinol | 9.05e-06 | 72 | 153 | 6 | CID000004644 | |
| Drug | 4'-hydroxywogonin | 1.02e-05 | 7 | 153 | 3 | CID005322078 | |
| Drug | D-G-G | 1.57e-05 | 23 | 153 | 4 | CID000444866 | |
| Drug | potassium cyanide | 1.61e-05 | 119 | 153 | 7 | CID000009032 | |
| Drug | AC1L96SZ | 2.13e-05 | 50 | 153 | 5 | CID000439166 | |
| Drug | Vanadium | 2.29e-05 | 173 | 153 | 8 | ctd:D014639 | |
| Drug | Taurine | 2.72e-05 | 129 | 153 | 7 | ctd:D013654 | |
| Drug | Mefloquine hydrochloride [51773-92-3]; Up 200; 9.6uM; PC3; HT_HG-U133A | 2.81e-05 | 178 | 153 | 8 | 2048_UP | |
| Drug | ebselen | 3.00e-05 | 131 | 153 | 7 | CID000003194 | |
| Drug | acetylaminophenylarsine oxide | 3.45e-05 | 10 | 153 | 3 | CID006337999 | |
| Drug | mivazerol | 3.45e-05 | 10 | 153 | 3 | CID000060783 | |
| Drug | C-PP | 3.54e-05 | 28 | 153 | 4 | CID000001228 | |
| Drug | NSC-6354 | 3.70e-05 | 92 | 153 | 6 | CID000221534 | |
| Drug | Furosemide [54-31-9]; Up 200; 12uM; HL60; HG-U133A | 4.82e-05 | 192 | 153 | 8 | 1580_UP | |
| Drug | Deoxycorticosterone [64-85-7]; Up 200; 12.2uM; HL60; HT_HG-U133A | 5.38e-05 | 195 | 153 | 8 | 3099_UP | |
| Drug | Dilazep dihydrochloride [20153-98-4]; Up 200; 6uM; HL60; HT_HG-U133A | 5.38e-05 | 195 | 153 | 8 | 2333_UP | |
| Drug | methylglyoxal bis(guanylhydrazone | 5.64e-05 | 61 | 153 | 5 | CID000009991 | |
| Drug | Sulfamethizole [144-82-1]; Down 200; 14.8uM; HL60; HT_HG-U133A | 5.78e-05 | 197 | 153 | 8 | 2536_DN | |
| Drug | Cefepime hydrochloride [123171-59-5]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 5.78e-05 | 197 | 153 | 8 | 6237_UP | |
| Drug | 1 Tc1 | 5.91e-05 | 100 | 153 | 6 | CID000083786 | |
| Disease | Wiskott-Aldrich syndrome (implicated_via_orthology) | 4.63e-07 | 4 | 145 | 3 | DOID:9169 (implicated_via_orthology) | |
| Disease | alpha-Mannosidosis | 2.40e-05 | 2 | 145 | 2 | C0024748 | |
| Disease | Autoinflammatory disorder | 2.60e-05 | 35 | 145 | 4 | C3860213 | |
| Disease | oculocutaneous albinism (is_implicated_in) | 1.43e-04 | 4 | 145 | 2 | DOID:0050632 (is_implicated_in) | |
| Disease | phenylketonuria (implicated_via_orthology) | 1.43e-04 | 4 | 145 | 2 | DOID:9281 (implicated_via_orthology) | |
| Disease | Thoracic Diseases | 1.43e-04 | 4 | 145 | 2 | C0039978 | |
| Disease | ribitol measurement | 2.38e-04 | 5 | 145 | 2 | EFO_0800143 | |
| Disease | Colorectal cancer | 3.12e-04 | 27 | 145 | 3 | cv:C0346629 | |
| Disease | COLORECTAL CANCER | 3.12e-04 | 27 | 145 | 3 | 114500 | |
| Disease | Neoplasm of the large intestine | 3.12e-04 | 27 | 145 | 3 | cv:C0009404 | |
| Disease | colorectal cancer (is_implicated_in) | 3.36e-04 | 121 | 145 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | Human papillomavirus infectious disease (is_implicated_in) | 3.55e-04 | 6 | 145 | 2 | DOID:11166 (is_implicated_in) | |
| Disease | Hyperphosphatasia-intellectual disability syndrome | 3.55e-04 | 6 | 145 | 2 | cv:C1855923 | |
| Disease | trefoil factor 1 measurement | 3.55e-04 | 6 | 145 | 2 | EFO_0021865 | |
| Disease | Cystic kidney | 3.55e-04 | 6 | 145 | 2 | C0022679 | |
| Disease | Hyperphosphatasia with Mental Retardation | 4.96e-04 | 7 | 145 | 2 | C1855923 | |
| Disease | glucose measurement | 6.06e-04 | 380 | 145 | 8 | EFO_0004468 | |
| Disease | metastatic colorectal cancer, survival time | 6.59e-04 | 8 | 145 | 2 | EFO_0000714, EFO_1001480 | |
| Disease | Industrial Dermatosis | 6.59e-04 | 8 | 145 | 2 | C0086457 | |
| Disease | Dermatitis, Occupational | 6.59e-04 | 8 | 145 | 2 | C0028796 | |
| Disease | Osteitis Deformans | 8.44e-04 | 9 | 145 | 2 | C0029401 | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 8.44e-04 | 9 | 145 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | Colon Carcinoma | 8.44e-04 | 9 | 145 | 2 | C0699790 | |
| Disease | hypertension (biomarker_via_orthology) | 9.28e-04 | 227 | 145 | 6 | DOID:10763 (biomarker_via_orthology) | |
| Disease | colon cancer (biomarker_via_orthology) | 9.33e-04 | 39 | 145 | 3 | DOID:219 (biomarker_via_orthology) | |
| Disease | human papilloma virus infection, oral cavity cancer | 1.16e-03 | 42 | 145 | 3 | EFO_0001668, EFO_0005570 | |
| Disease | atopic dermatitis (implicated_via_orthology) | 1.28e-03 | 11 | 145 | 2 | DOID:3310 (implicated_via_orthology) | |
| Disease | Cystic Kidney Diseases | 1.28e-03 | 11 | 145 | 2 | C1691228 | |
| Disease | Diabetes Mellitus, Insulin-Dependent | 1.42e-03 | 45 | 145 | 3 | C0011854 | |
| Disease | Carcinoma, Neuroendocrine | 1.53e-03 | 12 | 145 | 2 | C0206695 | |
| Disease | hypothyroidism (implicated_via_orthology) | 1.81e-03 | 13 | 145 | 2 | DOID:1459 (implicated_via_orthology) | |
| Disease | cortisol measurement, response to corticosteroid, response to synacthen | 1.81e-03 | 13 | 145 | 2 | EFO_0005843, EFO_0009175, GO_0031960 | |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 2.10e-03 | 14 | 145 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | myeloid cell surface antigen CD33 measurement | 2.41e-03 | 15 | 145 | 2 | EFO_0008238 | |
| Disease | Carcinoma of Endocrine Gland | 2.41e-03 | 15 | 145 | 2 | C1704374 | |
| Disease | Polydactyly | 2.70e-03 | 117 | 145 | 4 | C0152427 | |
| Disease | Glycogen storage disease | 3.11e-03 | 17 | 145 | 2 | cv:C0017919 | |
| Disease | uridine diphosphate galactose measurement, uridine diphosphate glucose measurement | 3.11e-03 | 17 | 145 | 2 | EFO_0010543, EFO_0010544 | |
| Disease | phosphatidylcholine 40:6 measurement | 3.11e-03 | 17 | 145 | 2 | EFO_0010389 | |
| Disease | Familial Progressive Myoclonic Epilepsy | 3.11e-03 | 17 | 145 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 3.11e-03 | 17 | 145 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 3.11e-03 | 17 | 145 | 2 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 3.11e-03 | 17 | 145 | 2 | C0751780 | |
| Disease | May-White Syndrome | 3.11e-03 | 17 | 145 | 2 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 3.11e-03 | 17 | 145 | 2 | C0751781 | |
| Disease | Action Myoclonus-Renal Failure Syndrome | 3.48e-03 | 18 | 145 | 2 | C0751779 | |
| Disease | Adenocarcinoma of lung (disorder) | 3.58e-03 | 206 | 145 | 5 | C0152013 | |
| Disease | venous thromboembolism, fibrinogen measurement | 4.42e-03 | 67 | 145 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | HIV-1 infection, Susceptibility to viral and mycobacterial infections | 4.74e-03 | 21 | 145 | 2 | EFO_0000180, Orphanet_391311 | |
| Disease | disease of metabolism (implicated_via_orthology) | 4.74e-03 | 21 | 145 | 2 | DOID:0014667 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EDFVHPGHGDLSGWA | 191 | P13051 | |
| SHFWGFQTHDVLPDI | 331 | Q9BYV1 | |
| HSLLEGCFPGGVHWV | 171 | O14727 | |
| HGAGLTHLLFLPDWA | 426 | Q5NDL2 | |
| FGNTDGSPHCVFWDH | 706 | Q8IZF5 | |
| GSPHCVFWDHSLFQG | 711 | Q8IZF5 | |
| SWGSAGHDGEPHDLT | 411 | Q8TDY4 | |
| EGIHDSFFEREHPGW | 911 | P78363 | |
| FGEEHSANPFHWDLI | 1861 | P78363 | |
| AGHAVAGWYLEHADP | 576 | Q9Y4W6 | |
| GHPAPSWVAFAHTGA | 171 | P0CJ87 | |
| DGHWHTFLIGKNGTA | 4301 | Q6V0I7 | |
| VGWTPAHFAAEAGHL | 76 | B4E2M5 | |
| SWAEEHGVYHPGQSS | 466 | Q8IYT2 | |
| DTGHNTSAPAHWGEL | 6 | P35368 | |
| WTDSAGPHPHGHEAE | 141 | Q99767 | |
| GHPAPSWVAFAHTGA | 171 | P0CJ89 | |
| EETGFWFIFHHVPTG | 691 | Q8WUJ3 | |
| VWVINIGHFADPAHG | 271 | Q93084 | |
| IGHFADPAHGGSWLR | 276 | Q93084 | |
| HNGHITGIDWAPKSD | 51 | Q92747 | |
| AWVTAGFLHIPHAED | 676 | Q16853 | |
| ADHHHRGTDFGGSPW | 46 | Q92617 | |
| SHPKGFSGWAHLTEV | 96 | O43374 | |
| HGAFPVHSQGVWAST | 71 | A6NC62 | |
| SHPKGFSGWAHLTEV | 96 | C9J798 | |
| IPADSLEWHENLGHG | 516 | P52333 | |
| WGSPIGKHHGADDSR | 126 | O75747 | |
| QGAGGSPVSWEHFFH | 546 | Q92621 | |
| ADHHHRGTDFGGSPW | 46 | F8W0I5 | |
| HGWVLGEHGDSSVPV | 186 | P00338 | |
| LHGDEHLSWFCSPAA | 41 | Q5SQ64 | |
| ALSEDHAWVVFGPNG | 181 | O00255 | |
| GDSAGAHFHISPEWI | 261 | P28039 | |
| HDGYHPTSVAEWLDS | 881 | Q7Z6G8 | |
| LDGPFGEGHQEWHKF | 1366 | Q9NRD9 | |
| FLLLPFHSGWDPDHG | 286 | P51606 | |
| RQFHFTSWPDHGVPD | 1196 | Q12913 | |
| HQPFLHAEGGTAGSW | 126 | Q6ZST4 | |
| GHPAPSWVAFAHTGA | 171 | Q9UBX2 | |
| HLWGSHGNSTFPEFL | 311 | Q9BZS1 | |
| DGGSWHVDQRPFVGH | 246 | Q9BQ67 | |
| WHPQDSGVFAASGAD | 361 | Q9BQ67 | |
| DRSADWLGLFAPHHG | 71 | A8MXV4 | |
| TAGDSWHQPSLFRHD | 61 | Q9HC44 | |
| WHQPSLFRHDSVDSG | 66 | Q9HC44 | |
| LPGAGIPFWSHHGDA | 46 | Q9HAT1 | |
| IPFWSHHGDAILGLE | 51 | Q9HAT1 | |
| HEWAPGGALTADAEA | 101 | Q9UJ90 | |
| VFHSPVGVGGWQHFD | 2681 | Q5SZK8 | |
| SDSAGIGFRHLPHWN | 21 | Q8NFR9 | |
| AAWEEVAGHHADRGP | 81 | Q92615 | |
| PFGEGHQEWHKFEVS | 1366 | Q9NRD8 | |
| DFHVGAHVNTFWRTP | 1301 | Q10570 | |
| GHPAPSWVAFAHTGA | 171 | P0CJ86 | |
| WLIAFAHGDLAPSEG | 91 | Q14654 | |
| PAVSHDWTFHGPGAT | 221 | Q9NS67 | |
| HIHIYSASWGPEDDG | 251 | Q6UW60 | |
| LLTGFPGLEAAHHWI | 11 | Q9Y5P1 | |
| PGLEEAHHWISVFFL | 16 | Q9H339 | |
| LYGGPWDVHVHSDLA | 26 | Q6UN15 | |
| GHEHSSHAWAEVPEG | 746 | Q96JK2 | |
| GDSHLGEIWVNSPHT | 1386 | Q9P265 | |
| FGQFDPVSHEWTDGI | 1581 | Q6ZR08 | |
| PAARHSHVAVAWAGS | 276 | Q7Z7M0 | |
| AAWAQGSTAHHLGPA | 126 | Q03052 | |
| HPTSCHGWIIGEHGD | 181 | P07864 | |
| HGWIIGEHGDSSVPL | 186 | P07864 | |
| SDGSLVSFTHWHPFE | 456 | Q9UBG0 | |
| VLHSPSAHFTGRWDD | 1081 | Q9UBG0 | |
| ADHHHRGTDFGGSPW | 46 | A8MRT5 | |
| PGETWSDAGNHCVTH | 5466 | P98088 | |
| GNHILPDEDLASFHW | 241 | Q9NZB2 | |
| FRLLAGPHEGHWNVF | 396 | Q6WN34 | |
| ADHRHRGTDFGGSPW | 46 | E9PIF3 | |
| ADHHHRGTDFGGSPW | 46 | C9JG80 | |
| DGEGPIHHGVCSSWL | 1206 | P29475 | |
| ELRLFHFTSWPDHGV | 1041 | O14522 | |
| ADHHHRGTDFGGSPW | 46 | E5RHQ5 | |
| GAGTGELLWDVHSHV | 6321 | Q5VST9 | |
| FELHTWSELPHGSGL | 826 | Q8N0W3 | |
| APATWSAHELGHAVG | 331 | Q9UKF2 | |
| FHSGPRGTHDLWDSR | 311 | Q04446 | |
| AWAPDGELFAVGSFH | 236 | Q9P2H3 | |
| GTRLAWLAEPDAHSH | 31 | P48547 | |
| DHDGGFWLVHSVPNF | 121 | O00115 | |
| FGIAHTRWATHGVPS | 86 | O94808 | |
| FLTVDLHVWPDFHGN | 381 | Q96C11 | |
| LEGHDRGVNWAAFHP | 201 | P53621 | |
| WHFKEDGTIFHPHSG | 531 | Q8N4A0 | |
| HIHIYSASWGPEDDG | 246 | P09958 | |
| SFAWGLEPHSHGARS | 561 | O15169 | |
| GHPAPSWVAFAHTGA | 171 | Q6RFH8 | |
| GNHILPDEDLAAFHW | 316 | Q9NX05 | |
| DDHGFSPLHWACREG | 31 | Q13418 | |
| PSLSHGSFHTAWGIL | 181 | Q96LW7 | |
| WHDHSVPVEGFGPTF | 161 | P28067 | |
| HGDAGDSLSWHNDKP | 381 | Q8NI99 | |
| GHPAPSWVAFAHTGA | 171 | P0CJ90 | |
| VAWHIDPFGHSREQA | 191 | O00754 | |
| PHHTFFWEGLDGSRV | 406 | Q9NTJ4 | |
| AVIFLHGLGDTGHSW | 26 | O95372 | |
| GCNLAEPEVAGHWSH | 211 | Q8NEP7 | |
| EAASGAHAGLGHIPW | 166 | Q9Y5J3 | |
| EIGAHHLGFLWASVA | 281 | O75881 | |
| AVFTRSSAHGPWHEA | 1076 | Q86VF2 | |
| GHQFFPWIHIGDLAG | 186 | Q9NRG7 | |
| GTMPWGHPGEHHDFE | 536 | Q13574 | |
| LGDSHLGEIWVSSPH | 1381 | Q14689 | |
| GFSHHSAWLVVLPAE | 346 | P22607 | |
| GHPAPSWVAFAHTGA | 171 | P0CJ88 | |
| HDGEGSPVWYHIVGS | 91 | B5MCN3 | |
| TCHDVDPTGDWGDIH | 251 | O95965 | |
| DFWFEAVGPTHSAHS | 26 | Q16617 | |
| ADHHHRGTDFGGSPW | 46 | A6NJU9 | |
| QFHFHGWPEVGIPSD | 691 | P18433 | |
| HGSWERFTGHNSPLF | 216 | Q12889 | |
| SGTDDFNVWIGLHDP | 91 | P05451 | |
| GDRAEGSPHFHLEWA | 146 | Q693B1 | |
| EIHLHWPGFEVSGSD | 296 | Q5JXM2 | |
| HHPAQGFRFGTVWES | 686 | O60391 | |
| GGLSLPHAEAHEFWK | 176 | Q8ND04 | |
| LLQHGAAPAWFHGFI | 86 | Q9NP31 | |
| LAGHAAWGIHGVPTS | 61 | Q9H606 | |
| HDFLGDSWGILFSHP | 26 | P30041 | |
| LPLDEKGHVTWSFHG | 526 | Q05209 | |
| KGHVTWSFHGPENAI | 531 | Q05209 | |
| TWSAEAHGLAPDGDV | 191 | Q9Y6E7 | |
| FGWIPDGHFSIPHAF | 201 | Q8IVJ1 | |
| KEHWTPEGHSIVGFA | 61 | P21673 | |
| EFLPVHWHSSLGGDA | 496 | Q9Y6Y8 | |
| PHFDWVVAHIGSSFP | 221 | Q6P9B9 | |
| SDPVHGYWFRAGDHV | 56 | Q96PQ1 | |
| PFGHLSEGFSHSRWL | 171 | Q13501 | |
| WQDFFTGHVVGEPDS | 111 | P78536 | |
| HAYEGVPNGGWHTSS | 286 | Q96P48 | |
| SELKHWATFAVGPGH | 151 | Q9UQ49 | |
| VEGLLGGLSHWDAEH | 56 | Q9NUD9 | |
| QRSWETLPFGHTHFD | 1266 | Q9Y4G8 | |
| TEGGHFPLHSPTFSW | 6 | Q8IUA0 | |
| VDFSHEGPAFLTWHR | 211 | P17643 | |
| WVQLHHPGSGEEAVA | 101 | O14709 | |
| HHGGGTVLPSESFSW | 236 | Q7Z2Z1 | |
| GFSSGRHHWEVEVGS | 391 | Q9C029 | |
| AFGEWTEIPGAHHII | 221 | Q9NWM0 | |
| PEAEEWGSHHGGLQE | 266 | Q9Y5U2 | |
| GGSILDPHWVLTAAH | 231 | Q9NRS4 | |
| HVSHVGWDPQNGFDV | 246 | P42768 | |
| LVAGHYPVWSIAEHG | 201 | P13686 | |
| GDAAIWPDAFHCEGT | 386 | Q4G0T1 | |
| VRASHDGWASFCDHP | 181 | Q6ZSY5 | |
| LWAPAADTHEGHITS | 56 | Q15904 | |
| HIPEDDFANGSWVHL | 116 | Q9P2J2 | |
| AIDFSHQGPAFVTWH | 206 | P40126 | |
| TDWGSHGAGHPSETL | 266 | O95427 | |
| SAAAHGAALLSHWDP | 71 | Q9H832 | |
| AWFAFDPGSAHSDII | 536 | Q9C026 | |
| GLDWHPDSEHILATS | 196 | Q6PJI9 | |
| PGHWDADAAEAATAF | 186 | Q96S55 | |
| NGEFATHHSPDSWIS | 186 | Q9UJ78 | |
| HWHAAFVGFPEGHGS | 916 | Q8TEQ8 | |
| TALGRAWHPEHFVCG | 241 | O43294 | |
| HIGHVGWDPNTGFDL | 211 | O00401 | |
| AVAWHPVHEGLFASG | 336 | Q9C0J8 | |
| APWDNHVSGHALFTE | 31 | Q96N03 | |
| TWKISDVAGPHGDHS | 41 | Q6ZVU0 | |
| ECPGLHTFLLWSHSG | 761 | Q7Z4V0 | |
| TALAEPAWLHIHGGT | 46 | O75204 | |
| EESGFLPHSHKIGLW | 146 | O15321 | |
| GHPAPSWVAFAHTGA | 171 | P0CJ85 | |
| GNHRDSWVHGAVDPS | 366 | Q9UQQ1 | |
| DWSAFAVITSLHPGH | 161 | Q14957 |